CB-36-TO28_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, [(9Z,19Z,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (Novartis, 135932822)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/135932822
Similar Terms
Downloads & Tools

Genes

5 genes differentially expressed following the CB-36-TO28_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 0.522644
FKBP1A FK506 binding protein 1A, 12kDa 0.319136
CSDE1 cold shock domain containing E1, RNA-binding 0.269524

decreased expression

Symbol Name Standardized Value
NBAS neuroblastoma amplified sequence -0.312525
JPT1 Jupiter microtubule associated homolog 1 -0.237852